Ajeeta B. Dash
0000-0001-5714-8354
3 papers found
Refreshing results…
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Missing publications? Search for publications with a matching author name.